| Financial Year |
March 31 2023 |
| Monetary Funds |
210,777,522.66 |
| Held-for-trading Financial Assets |
401,265,553.42 |
| Notes Receivable |
15,874,965.31 |
| Accounts Receivable |
34,357,396.52 |
| Advances to Suppliers |
2,857,828.01 |
| Other Receivables |
4,712,613.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
26,853,993.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
885,519.65 |
| Total Current Assets |
697,585,391.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
219,505,052.47 |
| Under-construction Projects |
46,809,863.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,362,760.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,638,693.46 |
| Other Non-Current Assets |
13,678,954.63 |
| Sub-Total of Non-Current Assets |
313,995,324.43 |
| Total Assets |
1,011,580,716.26 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
6,504,082.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
95,181.34 |
| Taxes Payable |
3,023,065.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,260,290.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
402,358.83 |
| Sub-Total of Current Liabilities |
24,511,072.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
278,718.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,204,718.94 |
| Total Liabilities |
56,715,791.33 |
| Paid-In Capital(Or Share Stock) |
80,803,943.00 |
| Capital Surplus |
461,371,836.82 |
| Surplus Reserve |
59,903,333.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
352,785,811.53 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
954,864,924.93 |
| Owner's Equity（Stockholder's Equity） |
954,864,924.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,011,580,716.26 |
